))
AI’s and Spatial Biology’s Potential for Curing Cancer, w/ Nucleai CEO Avi Veidman
Manage episode 427147635 series 3503527
Contenido proporcionado por Jeff Wilser. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Jeff Wilser o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
For over 20 years, Avi Veidman served in the Israeli intelligence forces, and he used AI to to map the world. In the military he used AI for national defense, and he learned its power.
He then realized that just as AI could map a battlefield, it could map cancer cells in biopsies and pathology slides.
Enter Nucleai, his company that’s using AI to improve the science of “spatial biology,” which can ultimately unlock new treatments and cures…with cancer on their radar.
Avi and I get into how this all works, the staggering potential, and the real-world challenges that need to be overcome.
Nucleai
Merck’s $14 million investment in Nucleai:
62 episodios
Compartir
